prescription spending high-cost specialty drugs genetic and metabolic markers Related: FDA fast-tracking gene therapies
A prescription for wasteful spending
Using metabolic fingerprints to target medication therapy
Real world impact of pharmacogenetics testing
Journal of Medical Economics
![Jennifer Fuhrmann-Berger](https://images.benefitspro.com/cdn-cgi/image/format=auto,fit=contain/https://images.benefitspro.com/contrib/content/uploads/sites/415/2018/06/fuhrmann-berger-200-BeneCard.jpg)
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.